Train harder · Free ship $75+ · Gear up now
Login Register
how were glp 1 agonists discovered

how were glp 1 agonists discovered LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept GLP-1 Orals and Multi-Agonists: Advancing

SKU: 84488833231

4.3
USD27.34 USD53.34

Pay in 4 interest-free payments of $6.83 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

Description

2016 Apr;55(3):93140

how were glp 1 agonists discovered LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept GLP-1 Orals and Multi-Agonists: Advancing

Lipo-C peptide FAQ Q1: What is LIPO-C w/B12 used for in research

how were glp 1 agonists discovered LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept GLP-1 Orals and Multi-Agonists: Advancing

doi: 10.5935/0004-2749.20180081

how were glp 1 agonists discovered LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept GLP-1 Orals and Multi-Agonists: Advancing

Jimenez V, Jambrina C, Casana E, Sacristan V, Muoz S, Darriba S, Rod J, Mallol C, Garcia M, Len X et al

how were glp 1 agonists discovered LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept GLP-1 Orals and Multi-Agonists: Advancing
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Blog
Blog

US$ 26.28

4.2 (7 reviews)

recommand products